Plasma microbial cell-free DNA metagenomic sequencing for early detection of infection after liver transplantation: a prospective cohort study
- 1Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine , ,
- 2Department of Surgery, Yonsei University College of Medicine , ,
- 3Department of Laboratory Medicine, Yonsei University College of Medicine , ,
Abstract
Introduction
Microbial cell-free DNA (mcfDNA) metagenomic next-generation sequencing (mNGS) is a promising technique for diagnosing infectious diseases. However, research on mcfDNA-based mNGS for diagnosing infections in liver transplantation (LT) recipients remains limited. The aim of this study was to evaluate the diagnostic performance and clinical utility of plasma mcfDNA mNGS during the early post-LT period.Methods
In this prospective diagnostic cohort study, adult LT recipients underwent plasma mcfDNA mNGS on postoperative days 7 and 14. The findings were compared with results of the blood cultures and other conventional microbiological tests at the species level.Results
Among 193 LT recipients, mNGS positivity was observed in 14.5% on day 7 and 21.8% on day 14. The concordance between mNGS and blood culture for bacterial pathogens was modest on days 7 (35.0%) and 14 (14.3%) but increased substantially when other clinically relevant specimens were included (80.0% and 71.4%, respectively). mNGS identified additional pathogens not detected using blood culture in 59.3% and 74.2% of cases on days 7 and 14, respectively. Viral pathogens, including cytomegalovirus, herpes simplex virus, varicella-zoster virus, and roseolovirus, were also detected. Among the 13 discordant cases (blood culture-positive and mNGS-negative), two (15.4%) were classified as contamination/colonization, five (38.5%) as weak positives, and six (46.2%) as not detected by mNGS.Conclusion
Plasma mcfDNA mNGS demonstrated substantial concordance with conventional microbiological testing when clinically relevant specimens were considered. mNGS may serve as a useful adjunct tool for early pathogen detection and clinical assessment of LT recipients.
Related
- Metagenomic Next-Generation Sequencing Enhances Pathogen Detection and Prognostic Stratification in Hematopoietic Stem Cell Transplantation Recipients.
- Plasma and Serum Metagenomic Sequencing of Microbial Cell-Free Nucleic Acids for Suspected Central Nervous System Infection: A Systematic Review
- Distinct Anaerobic Microbial Signature Differentiates Anal Squamous Cell Carcinoma From High-Grade Squamous Intraepithelial Lesions: A Prospective Metagenomic Study
- Bronchoalveolar Lavage Metagenomic Sequencing in the Early Post-Lung Transplantation Period: A Pilot Comparison with Microbiologic Culture
- Characterization of lower-airway microbial communities in pulmonary tuberculosis by BALF metagenomic sequencing
BibTeX
@article{lee2026plasma,
title = {{Plasma microbial cell-free DNA metagenomic sequencing for early detection of infection after liver transplantation: a prospective cohort study}},
author = {Yongseop Lee and Eun-Ki Min and Yu Jin Park and Deok-Gie Kim and Dong Jin Joo and Myoung Soo Kim and Saeam Shin and Seung-Tae Lee and Jae Geun Lee and Su Jin Jeong},
journal = {Frontiers in cellular and infection microbiology},
year = {2026},
month = oct,
doi = {10.3389/fcimb.2026.1930701},
url = {https://europepmc.org/article/PMC/PMC13716750},
note = {CC BY},
}
RIS
TY - JOUR
TI - Plasma microbial cell-free DNA metagenomic sequencing for early detection of infection after liver transplantation: a prospective cohort study
AU - Yongseop Lee
AU - Eun-Ki Min
AU - Yu Jin Park
AU - Deok-Gie Kim
AU - Dong Jin Joo
AU - Myoung Soo Kim
AU - Saeam Shin
AU - Seung-Tae Lee
AU - Jae Geun Lee
AU - Su Jin Jeong
PY - 2026
DA - 2026/10/15
JO - Frontiers in cellular and infection microbiology
DO - 10.3389/fcimb.2026.1930701
UR - https://europepmc.org/article/PMC/PMC13716750
AB - Introduction Microbial cell-free DNA (mcfDNA) metagenomic next-generation sequencing (mNGS) is a promising technique for diagnosing infectious diseases. However, research on mcfDNA-based mNGS for diagnosing infections in liver transplantation (LT) recipients remains limited. The aim of this study was to evaluate the diagnostic performance and clinical utility of plasma mcfDNA mNGS during the early post-LT period.Methods In this prospective diagnostic cohort study, adult LT recipients underwent plasma mcfDNA mNGS on postoperative days 7 and 14. The findings were compared with results of the blood cultures and other conventional microbiological tests at the species level.Results Among 193 LT recipients, mNGS positivity was observed in 14.5% on day 7 and 21.8% on day 14. The concordance between mNGS and blood culture for bacterial pathogens was modest on days 7 (35.0%) and 14 (14.3%) but increased substantially when other clinically relevant specimens were included (80.0% and 71.4%, respectively). mNGS identified additional pathogens not detected using blood culture in 59.3% and 74.2% of cases on days 7 and 14, respectively. Viral pathogens, including cytomegalovirus, herpes simplex virus, varicella-zoster virus, and roseolovirus, were also detected. Among the 13 discordant cases (blood culture-positive and mNGS-negative), two (15.4%) were classified as contamination/colonization, five (38.5%) as weak positives, and six (46.2%) as not detected by mNGS.Conclusion Plasma mcfDNA mNGS demonstrated substantial concordance with conventional microbiological testing when clinically relevant specimens were considered. mNGS may serve as a useful adjunct tool for early pathogen detection and clinical assessment of LT recipients.
SN - 2235-2988
ER -